查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
人造器官与仿生植入物市场：现况分析与预测（2023-2030）
市场调查报告书
商品编码
1408700

人造器官与仿生植入物市场：现况分析与预测（2023-2030）

Artificial Organs & Bionic Implants Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2022年，人造器官和仿生植入物市场价值达350亿美元，预计2023年至2030年复合年增长率约10%。

按类型划分，市场分为人造器官和仿生植入物。到 2022 年，人造器官类别将占据重要的市场份额。该细分市场的成长主要是由于对肾臟、心臟、肺和肝臟移植的需求不断增加。例如，根据器官采购和移植网络的数据，美国总共进行了 24,669 例肾臟移植、9,236 例肝臟移植和 3,817 例心臟移植。在美国，肾臟移植的平均等待时间约为 5 年。因此，製造商正在透过开发生物製氧器、人工胰臟和穿戴式人工肾臟等创新解决方案来应对满足未满足需求的挑战。

依技术划分，市场分为机械市场和电子市场。其中，机械类将在2022年占据较大的市场份额。机械人造器官可用于帮助患有先天性疾病或出生缺陷的人。例如，人造器官可以帮助失去双手的人完成日常任务并过着更独立的生活。

为了更了解该产业的市场采用情况，市场包括北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、义大利、西班牙、欧洲其他地区）、亚太地区（中国、日本、印度）、韩国、澳洲以及亚太地区其他地区）以及世界其他地区。到 2022 年，北美将在周边脉搏血氧仪市场占据压倒性份额。每个国家成熟的医疗基础设施和不断增加的医疗支出是推动北美市场成长的主要因素。

目录

第一章 市场介绍

  • 市场定义
  • 主要目标
  • 利益相关者
  • 限制

第二章 研究方法或假设

  • 调查过程
  • 调查方法
  • 受访者简介

第三章市场总结

第 4 章执行摘要

第五章 全球人工器官及仿生植入物市场

第六章 COVID-19 对市场的影响

第七章 全球人造器官和仿生植入物市场收入（2020-2030）

第 8 章按类型划分的市场洞察

  • 人造器官
    • 人工心臟
    • 人工肾
    • 人工肺
    • 人工耳蜗
    • 其他器官类型
  • 仿生学
    • 视觉仿生学
    • 耳仿生学
    • 骨科仿生学
    • 其他仿生学

第九章技术市场洞察

  • 机械的
  • 电子的

第10章按地区划分的市场洞察

  • 北美
    • 美国
    • 加拿大
    • 北美其他地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区

第十一章：人造器官与仿生植入物市场动态

  • 市场驱动力
  • 市场挑战
  • 影响分析

第十二章人造器官与仿生植入物市场机会

第十三章 人工器官与仿生植入物市场趋势

第十四章需求面和供给面分析

  • 需求面分析
  • 供给侧分析

第十五章价值链分析

第16章 竞争场景

  • 竞争格局
    • 波特五力分析

第十七章公司简介

  • ABIOMED
  • Berlin Heart
  • Zimmer Biomet
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Edwards Lifesciences Corporation
  • Ekso Bionics
  • Medtronic
  • Jarvik Heart, Inc
  • SynCardia Systems, LLC.

第18章 免责声明

简介目录
Product Code: UMHE212512

Artificial organs and bionic implants are revolutionary technologies that aim to restore or enhance the functionality of a specific organ or system in the human body. These advancements have the potential to significantly improve the quality of life for individuals with organ failure, disability, or degenerative diseases. For Instance, as per the data of Organ Procurement & Transplantation Network, in year 2021, 41,354 organ transplants were performed in the United States, an increase of 5.9 percent over 2020. The demand for artificial organs and bionic implants arises from the need to replace or support the functioning of damaged or non-functional organs. the increasing prevalence of chronic diseases, technological advancements, the aging population, growing awareness, and supportive policies have collectively acted as significant drivers for the Artificial Organs & Bionic Implants market.

Artificial Organs and Bionic Implants Market was valued at USD 35,000 Million in 2022 and is expected to grow at a CAGR of around 10% from 2023-2030.

Based on the Type, the market is segmented into artificial organs and Bionics. The artificial organs category hold considerable share of the market in 2022. The segment is experiencing growth primarily due to the increasing demand for kidney, heart, lung, and liver transplants. For Instance, as per the data of Organ Procurement & Transplantation Network, there were totals of 24,669 kidney transplants, 9,236 liver transplants and 3,817 heart transplants in US. In the United States, the average median waiting time for a kidney transplant is approximately 5 years. Consequently, manufacturers have been motivated to address the challenge of meeting the unmet demand by developing innovative solutions such as bio-lungs, artificial pancreas, and wearable artificial kidneys.

Based on Technology, the market is categorized into Mechanical and Electronic. Among these, the Mechanical category held a significant share of the market in 2022. Mechanical artificial organs can be used to assist individuals with congenital disabilities or birth defects. For instance, a prosthetic device can help someone with a missing hand to perform daily tasks and lead a more independent life.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North America held dominating share of Peripheral Pulse Oximeters Market in 2022. The presence of well-established healthcare infrastructure, along with the increasing healthcare expenditure in the countries is the major attributing factor for the market growth in North America.

Some of the major players operating in the market include: ABIOMED; Berlin Heart; Zimmer Biomet; Boston Scientific Corporation; Cochlear Ltd.; Edwards Lifesciences Corporation; Ekso Bionics; Medtronic; Jarvik Heart, Inc; and SynCardia Systems, LLC. etc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Artificial Organs & Bionic Implants Market
  • 2.2. Research Methodology of the Artificial Organs & Bionic Implants Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL ARTIFICIAL ORGANS & BIONIC IMPLANTS MARKET

6 MARKET COVID-19 IMPACT

7 GLOBAL ARTIFICIAL ORGANS & BIONIC IMPLANTS MARKET REVENUE, 2020-2030F

8 MARKET INSIGHTS BY TYPE

  • 8.1. Artificial Organ
    • 8.1.1. Artificial Heart
    • 8.1.2. Artificial Kidney
    • 8.1.3. Artificial Lungs
    • 8.1.4. Cochlear Implants
    • 8.1.5. Other Organ Types
  • 8.2. Bionics
    • 8.2.1. Vision Bionics
    • 8.2.2. Ear Bionics
    • 8.2.3. Orthopedic Bionic
    • 8.2.4. Other Bionics

9 MARKET INSIGHTS BY TECHNOLOGY

  • 9.1. Mechanical
  • 9.2. Electronic

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Artificial Organs & Bionic Implants Market
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Artificial Organs & Bionic Implants Market
    • 10.2.1. Germany
    • 10.2.2. UK
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific Artificial Organs & Bionic Implants Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of APAC
  • 10.4. Rest of the World Artificial Organs & Bionic Implants Market

11 ARTIFICIAL ORGANS & BIONIC IMPLANTS MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 ARTIFICIAL ORGANS & BIONIC IMPLANTS MARKET OPPORTUNITIES

13 ARTIFICIAL ORGANS & BIONIC IMPLANTS MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1. ABIOMED
  • 17.2. Berlin Heart
  • 17.3. Zimmer Biomet
  • 17.4. Boston Scientific Corporation
  • 17.5. Cochlear Ltd.
  • 17.6. Edwards Lifesciences Corporation
  • 17.7. Ekso Bionics
  • 17.8. Medtronic
  • 17.9. Jarvik Heart, Inc
  • 17.10. SynCardia Systems, LLC.

18 DISCLAIMER